(Q40563597)

21 September 2017

title

Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors (English)

1 reference

21 September 2017

Corbière V

1

1 reference

21 September 2017

Nicolay H

2

1 reference

21 September 2017

Russo V

3

1 reference

21 September 2017

Stroobant V

4

1 reference

21 September 2017

Brichard V

5

1 reference

21 September 2017

Boon T

6

1 reference

21 September 2017

van der Bruggen P

7

1 reference

21 September 2017

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

63

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

453-457

1 reference

Tumor-specific shared antigenic peptides recognized by human T cells

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Proliferating dendritic cell progenitors in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00203.X

10.1111/J.0001-2815.2004.00203.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference